跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11 条关于
“BiTAC”
全部
11
临床试验
6
药物
0
机构
0
资讯
5
9个月前
Veraxa Biotech's Nasdaq Listing Back on Track After US Government Shutdown Delays
去年
VERAXA Biotech and Voyager Acquisition to Merge, Creating $1.64B NASDAQ-Listed Cancer Therapeutics Company
去年
VERAXA Biotech Appoints Oncology Veteran Rick Austin as Chief Scientific Officer to Advance Novel Cancer Therapies
去年
VeGen Labs Receives ₹3.765 Crore BIRAC Grant to Advance Novel KRAS Inhibitor for Lung Cancer Treatment
7个月前
Personalized T-Cell Activator iTAC-XS15-CLL01 Demonstrates Safety and Immunogenicity in Phase 1 Chronic Lymphocytic Leukemia Trial